BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 16713953)

  • 1. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.
    Frye M; Watt FM
    Curr Biol; 2006 May; 16(10):971-81. PubMed ID: 16713953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability.
    Hussain S; Benavente SB; Nascimento E; Dragoni I; Kurowski A; Gillich A; Humphreys P; Frye M
    J Cell Biol; 2009 Jul; 186(1):27-40. PubMed ID: 19596847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer.
    Frye M; Dragoni I; Chin SF; Spiteri I; Kurowski A; Provenzano E; Green A; Ellis IO; Grimmer D; Teschendorff A; Zouboulis CC; Caldas C; Watt FM
    Cancer Lett; 2010 Mar; 289(1):71-80. PubMed ID: 19740597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human tRNA m (5) C methyltransferase Misu is multisite-specific.
    Auxilien S; Guérineau V; Szweykowska-Kulińska Z; Golinelli-Pimpaneau B
    RNA Biol; 2012 Nov; 9(11):1331-8. PubMed ID: 22995836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.
    Shi Q; Wang W; Jia Z; Chen P; Ma K; Zhou C
    Oncotarget; 2016 Jun; 7(24):36489-36500. PubMed ID: 27183908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG10 is a c-MYC target gene in cancer cells.
    Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
    Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-methyltransferase Misu (NSun2) poises epidermal stem cells to differentiate.
    Blanco S; Kurowski A; Nichols J; Watt FM; Benitah SA; Frye M
    PLoS Genet; 2011 Dec; 7(12):e1002403. PubMed ID: 22144916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m
    Chen L; Ding J; Wang B; Chen X; Ying X; Yu Z; Dong P
    Exp Cell Res; 2021 Jul; 404(2):112664. PubMed ID: 34048786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSun2 Promotes Cell Growth via Elevating Cyclin-Dependent Kinase 1 Translation.
    Xing J; Yi J; Cai X; Tang H; Liu Z; Zhang X; Martindale JL; Yang X; Jiang B; Gorospe M; Wang W
    Mol Cell Biol; 2015 Dec; 35(23):4043-52. PubMed ID: 26391950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo.
    Wang YH; Liu S; Zhang G; Zhou CQ; Zhu HX; Zhou XB; Quan LP; Bai JF; Xu NZ
    Breast Cancer Res; 2005; 7(2):R220-8. PubMed ID: 15743499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I.
    Grandori C; Gomez-Roman N; Felton-Edkins ZA; Ngouenet C; Galloway DA; Eisenman RN; White RJ
    Nat Cell Biol; 2005 Mar; 7(3):311-8. PubMed ID: 15723054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin enhances c-Myc-mediated transcription to promote cancer progression.
    Wu G; Yuan M; Shen S; Ma X; Fang J; Zhu L; Sun L; Liu Z; He X; Huang D; Li T; Li C; Wu J; Hu X; Li Z; Song L; Qu K; Zhang H; Gao P
    Nat Commun; 2017 May; 8():15278. PubMed ID: 28474697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH; Zou L; Tu ZG
    J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57
    Mei L; Shen C; Miao R; Wang JZ; Cao MD; Zhang YS; Shi LH; Zhao GH; Wang MH; Wu LS; Wei JF
    Cell Death Dis; 2020 Apr; 11(4):270. PubMed ID: 32332707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
    Shchors K; Shchors E; Rostker F; Lawlor ER; Brown-Swigart L; Evan GI
    Genes Dev; 2006 Sep; 20(18):2527-38. PubMed ID: 16980582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
    Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
    Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression of c-myc in the tissues of human laryngeal squamous cell carcinoma and the effect of siRNA-mediated inhibition of c-myc on proliferation in laryngeal carcinoma Hep-2 cells].
    Sang J; Liu L; Tian F; Jin H; Yuan L; Lou W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(15):695-700. PubMed ID: 22010341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.